Ankle Foot Orthosis on Muscle Activity in Cerebral Palsy
Launched by DELTA UNIVERSITY FOR SCIENCE AND TECHNOLOGY · Mar 1, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how two types of ankle foot orthoses (AFOs) can affect muscle activity in children with a condition called spastic diplegic cerebral palsy. The two AFOs being compared are a solid AFO, which provides more support, and a ground reaction AFO, which helps with movement differently. The trial aims to see which type of orthosis helps children aged 6 to 12 years old with their muscle function.
To participate in this study, children must have certain levels of tightness in their leg muscles and be able to follow simple instructions. However, children with certain sensory disorders, cognitive issues, or who have had Botox treatment in the last six months cannot join. Participants will have the opportunity to help researchers understand how these devices can improve movement and muscle use in children with cerebral palsy, potentially leading to better treatment options in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Spasticity level II in lower limb muscles according to Modified Ashworth Scale.
- • Able to follow order.
- • Aged from 6 to 12 years old.
- Exclusion Criteria:
- • Visual or obvious detected vestibular sensory disorders or cerebellar disease.
- • Botox injection in the last 6 months.
- • Cognitive deficits or disturbed conscious level.
About Delta University For Science And Technology
Delta University for Science and Technology is a leading academic institution dedicated to advancing healthcare through innovative research and clinical trials. With a commitment to excellence in education and scientific inquiry, the university fosters collaboration among multidisciplinary teams to explore new treatments and therapies. Its state-of-the-art facilities and experienced faculty support a rigorous approach to clinical research, ensuring adherence to the highest ethical standards and regulatory compliance. Delta University aims to contribute significantly to the understanding and advancement of medical science, ultimately improving patient outcomes and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported